CytRx Corporation (CYTR) Dividend History

CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is the aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).

Last update 05/25/2018


Dividend Yield Summary

  2013 2014 2015 2016 2017 2018
Dividends - - - - - -
Average Price 2.58 3.87 3.24 1.57 0.79 1.73
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2018 are year-to-date.

DivInfo Metrics ™

52-Week Projected Earnings Per Share -1.52
52-Week Projected Dividends Per Share 0.00
Dividend Cover -
52-Week Projected Yield -
52-Week Trailing Yield -
6-Year Average Yield -
6-Year Dividend Change -
6-Year Yearly Dividend Change -
Number of Dividend Payments (2008-03-07 - 2008-03-07) 1

Dividend History

Date Amount Per Share Note
2008-03-07 $1.74
What other features would you like to see on this site? Please send us your comments: